MedTrace Logo

Solutions for Atrial Fibrillation Edvocacy (SAFE)

NCT05067114 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 650

Last updated 2023-02-21

No results posted yet for this study

Summary

The aim of this demonstration project is to create an additional access point in the community at local pharmacies for atrial fibrillation screening, detection, and referral to physicians for follow-up and initiation of evidence-based therapy when appropriate.

Conditions

Interventions

DEVICE

Screening, detection and referral for atrial fibrillation

In-pharmacy cardiovascular risk assessment plus AliveCor KardiaMobile reading

Sponsors & Collaborators

  • American Pharmacists Association Foundation

    lead OTHER

Principal Investigators

  • Benjamin M Bluml, Pharmacy · American Pharmacists Association Foundation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-03
Primary Completion
2022-05-31
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05067114 on ClinicalTrials.gov